Skip to content
2000
Volume 30, Issue 38
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Long non-coding RNA (lncRNA) is a kind of biomolecule that can regulate important life activities such as cell proliferation, apoptosis, differentiation, aging, and body development. It has been found that lncRNAs are closely related to various diseases. In cardiovascular diseases, lncRNAs affect the expression level of related genes in atherosclerotic plaques, which are closely related to endothelial dysfunction, smooth muscle cell proliferation, macrophage dysfunction, abnormal lipid metabolism, and cellular autophagy, thus participating in regulating the occurrence and development of AS. In view of this, investigating the role of lncRNAs in regulating cardiac gene networks on cardiovascular system diseases has attracted much clinical attention and may be a novel target for AS therapy. This paper focuses on lncRNAs related to AS, explores the relationship between lncRNAs and AS, suggests the role of lncRNAs in the prevention and treatment of AS, and expects the application of more lncRNAs as the marker in the clinical diagnosis and treatment of AS.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867330666230111125141
2023-11-01
2025-03-15
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0929867330666230111125141
Loading

  • Article Type:
    Review Article
Keyword(s): atherosclerosis; biomarker; ceRNA; drug discovery; lncRNAs; prognosis
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test